Forging a position as an innovative player in
infectious disease vaccines and therapies

Home
About
Our Technology
Business Development
- Partner Network
- Licensing Strategy and Available Licenses
Investor Relations
Contact Us
- Corporate directory

BioDiem » » Opal announces acquisition of specialist formulation company Formulytica

Opal announces acquisition of specialist formulation company Formulytica May 5, 2021 • Category • Author Name

Opal announces acquisition of specialist formulation company Formulytica

Latest News

EOFY Share Valuation Information

August 10, 2026

EOFY Share Valuation Information

Read More
Half Yearly Financial Report

July 6, 2026

26-07-01 BioDiem Limited Half-year Financial Report 31Dec2025

Read More

Join our email list!

Join our email distribution list to be updated with announcements.

© Copyright 2014 BioDiem

Privacy Policy
Terms and conditions